Phase 3 Cardiovascular outcomes Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Recruiting
Phase 3
The effect of lower salt exposure at haemodialysis on cardiac micro-injury, in home and self-care haemodialysis patients.
Cardiovascular outcomes
The Centre for Clinical Research and effective practice (CCRep), registered with the New Zealand Charities Commission (ref# CC21537)118 enrolled1 locationACTRN12614000070639
Recruiting
Phase 3
The effect of lower salt exposure on the cardiac structure and function of patients on home haemodialysis
Cardiovascular outcomes in dialysis patients
The Centre for Clinical Research and effective practice (CCRep), registered with the New Zealand Charities Commission (ref# CC21537)118 enrolled1 locationACTRN12611000975998